rs454006

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_002739.5(PRKCG):​c.285+2624T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.36 in 152,146 control chromosomes in the GnomAD database, including 11,108 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.36 ( 11108 hom., cov: 32)

Consequence

PRKCG
NM_002739.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.138

Publications

19 publications found
Variant links:
Genes affected
PRKCG (HGNC:9402): (protein kinase C gamma) Protein kinase C (PKC) is a family of serine- and threonine-specific protein kinases that can be activated by calcium and second messenger diacylglycerol. PKC family members phosphorylate a wide variety of protein targets and are known to be involved in diverse cellular signaling pathways. PKC also serve as major receptors for phorbol esters, a class of tumor promoters. Each member of the PKC family has a specific expression profile and is believed to play distinct roles in cells. The protein encoded by this gene is one of the PKC family members. This protein kinase is expressed solely in the brain and spinal cord and its localization is restricted to neurons. It has been demonstrated that several neuronal functions, including long term potentiation (LTP) and long term depression (LTD), specifically require this kinase. Knockout studies in mice also suggest that this kinase may be involved in neuropathic pain development. Defects in this protein have been associated with neurodegenerative disorder spinocerebellar ataxia-14 (SCA14). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]
PRKCG Gene-Disease associations (from GenCC):
  • spinocerebellar ataxia type 14
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.552 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002739.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRKCG
NM_002739.5
MANE Select
c.285+2624T>C
intron
N/ANP_002730.1P05129-1
PRKCG
NM_001316329.2
c.285+2624T>C
intron
N/ANP_001303258.1A0A804HIU5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRKCG
ENST00000263431.4
TSL:1 MANE Select
c.285+2624T>C
intron
N/AENSP00000263431.3P05129-1
PRKCG
ENST00000682028.1
c.285+2624T>C
intron
N/AENSP00000507230.1A0A804HIU5
PRKCG
ENST00000683513.1
c.285+2624T>C
intron
N/AENSP00000506809.1A0A804HHY0

Frequencies

GnomAD3 genomes
AF:
0.360
AC:
54681
AN:
152028
Hom.:
11071
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.558
Gnomad AMI
AF:
0.330
Gnomad AMR
AF:
0.355
Gnomad ASJ
AF:
0.352
Gnomad EAS
AF:
0.312
Gnomad SAS
AF:
0.365
Gnomad FIN
AF:
0.220
Gnomad MID
AF:
0.354
Gnomad NFE
AF:
0.266
Gnomad OTH
AF:
0.376
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.360
AC:
54770
AN:
152146
Hom.:
11108
Cov.:
32
AF XY:
0.357
AC XY:
26558
AN XY:
74368
show subpopulations
African (AFR)
AF:
0.558
AC:
23161
AN:
41494
American (AMR)
AF:
0.354
AC:
5416
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.352
AC:
1221
AN:
3472
East Asian (EAS)
AF:
0.312
AC:
1618
AN:
5180
South Asian (SAS)
AF:
0.366
AC:
1764
AN:
4818
European-Finnish (FIN)
AF:
0.220
AC:
2326
AN:
10594
Middle Eastern (MID)
AF:
0.354
AC:
104
AN:
294
European-Non Finnish (NFE)
AF:
0.266
AC:
18057
AN:
67992
Other (OTH)
AF:
0.380
AC:
803
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1731
3461
5192
6922
8653
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
522
1044
1566
2088
2610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.297
Hom.:
31256
Bravo
AF:
0.377
Asia WGS
AF:
0.374
AC:
1299
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
4.4
DANN
Benign
0.44
PhyloP100
0.14
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs454006; hg19: chr19-54390121; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.